MANUFACTURERS LIFE INSURANCE COMPANY, THE
InsurancePosition in GERN — Geron Corp
CIK 928047
TORONTO, A6
Position in GERN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$190,600
-$30,916 QoQ
Shares Held
148,907
+0.2% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#101
of 258 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MANUFACTURERS LIFE INSURANCE COMPANY, THE holds $1,655,634,902 across 242 Biotechnology names. GERN ranks #179 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
554,085 | $275,230,642 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
893,795 | $269,059,108 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,955,733 | $145,662,993 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
539,037 | $129,891,745 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
2,988,121 | $105,749,602 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
147,961 | $92,259,601 | |
| 7 | RPRX |
Royalty Pharma plc
|
678,768 | $38,058,521 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
441,957 | $36,050,432 |
All Filings in GERN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $190,600 | 148,907 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $221,516 | 148,669 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $220,234 | 166,844 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $247,216 | 180,450 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $446,437 | 316,622 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $474,028 | 298,131 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,589,056 | 448,886 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,157,728 | 695,535 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,883,623 | 915,949 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,197,464 | 362,868 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $550,344 | 260,827 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $550,195 | 259,526 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $639,711 | 199,287 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $319,471 | 147,222 | Shares | Defined | 2023-05-15 | |
| 2021-12-31 | $210,755 | 172,750 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $245,235 | 179,004 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $266,119 | 188,737 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $274,864 | 173,965 | Shares | Defined | 2021-05-03 | |
| 2020-12-31 | $282,533 | 177,694 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $280,747 | 161,349 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $251,807 | 115,508 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $146,835 | 123,391 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||